Breaking
Cancer Research Institute’s William B. Coley Award: A Precursor to Nobel Recognition, Illuminating Decades of Immunological Breakthroughs
Vitamin D Analog Shows Promise in Reprogramming Pancreatic Cancer Microenvironment to Enhance Chemotherapy Efficacy
Why Childhood Cancer Is Different — and How Immunotherapy Research Is Changing the Landscape
University of Oklahoma Scientists Uncover How Aggressive Breast Cancer Hijacks Immune System to Promote Nerve Growth and Tumor Progression
Vitamin D Analog Shows Promise in Reprogramming the Pancreatic Tumor Microenvironment to Overcome Treatment Resistance
Forbion Secures Record €2.3 Billion Across Two Funds, Offering Critical Boost to European Biotech Sector
Colorectal Cancer Emerges as Leading Cause of Cancer Death in Adults Under 50, Prompting Urgent Public Health Call to Action
Advancing the Frontier of Pediatric Oncology: How Tailored Immunotherapies Are Revolutionizing Childhood Cancer Treatment
Beyond the Remission: The Complex Journey of a Childhood Cancer Survivor Navigating the Intersection of Physical Recovery and Mental Health Resilience
MEK Identified as Key Driver of T Cell Exhaustion in Cancer Immunotherapy, Offering New Therapeutic Avenues
16 Oct 2026, Fri

Biotech, Pharma & Cancer Drug Development

You Missed

Immunotherapy & CAR-T Research

Cancer Research Institute’s William B. Coley Award: A Precursor to Nobel Recognition, Illuminating Decades of Immunological Breakthroughs

Skin Cancer, Melanoma & Dermatology

Vitamin D Analog Shows Promise in Reprogramming Pancreatic Cancer Microenvironment to Enhance Chemotherapy Efficacy

Immunotherapy & CAR-T Research

Why Childhood Cancer Is Different — and How Immunotherapy Research Is Changing the Landscape

Breast Cancer: Research & Awareness

University of Oklahoma Scientists Uncover How Aggressive Breast Cancer Hijacks Immune System to Promote Nerve Growth and Tumor Progression